Physician profile
Michael J Hallisey
NPI 1821080235
$431,655.92
in general payments reported to CMS, 2019-2025
5 companies · $155K in 2025
The $155K reported for 2025 was more than what 99% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $121 · 2020: $1,678 · 2021: $9,019 · 2022: $52K · 2023: $86K · 2024: $127K · 2025: $155K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $364K · Consulting Fee: $4,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $363,897.84 |
| Consulting Fee | $4,442.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $431,359.10 | 2020-2025 | Safeguard Focus, Onevac, Mak-Nv Introducer System |
| W. L. Gore & Associates, INC. | $149.44 | 2021 | |
| Ethicon US, LLC | $94.16 | 2019 | |
| Medtronic Vascular, INC. | $40.21 | 2019-2020 | |
| Argon Medical Devices, INC. | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hallisey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.